Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 346 AL 360

Pesticides, cognitive functions and dementia: A review

Aloizou AM, Siokas V, Vogiatzi C, Peristeri E, Docea AO, Petrakis D, Provatas A, Folia V, Chalkia C, Vinceti M, Wilks M, Izotov BN, Tsatsakis A, Bogdanos DP, Dardiotis E.

Toxicol Lett. 2020 Jun 15;326:31-51. doi: 10.1016/j.toxlet.2020.03.005. Epub 2020 Mar 4.

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease

Uddin MS, Kabir MT, Niaz K, Jeandet P, Clément C, Mathew B, Rauf A, Rengasamy KRR, Sobarzo-Sánchez E, Ashraf GM, Aleya L.

Molecules. 2020 Mar 11;25(6):1267. doi: 10.3390/molecules25061267.

APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease

Lin AL, Parikh I, Yanckello LM, White RS, Hartz AMS, Taylor CE, McCulloch SD, Thalman SW, Xia M, McCarty K, Ubele M, Head E, Hyder F, Sanganahalli BG.

Neurobiol Dis. 2020 Jun;139:104834. doi: 10.1016/j.nbd.2020.104834. Epub 2020 Mar 12.

One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults

Martinez AI, Abner EL, Jicha GA, Rigsby DN, Eckmann LC, Huffmyer MJ, Moga DC.

J Manag Care Spec Pharm. 2020 Apr;26(4):520-528. doi: 10.18553/jmcp.2020.26.4.520.

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant

Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC.

Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.

Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach

Donohue MC, Model F, Delmar P, Volye N, Liu-Seifert H, Rafii MS, Aisen PS; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2020 May;16(5):797-803. doi: 10.1002/alz.12058. Epub 2020 Apr 8.

What works and what does not work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials

Bullain S, Doody R.

J Neurochem. 2020 Sep;155(2):120-136. doi: 10.1111/jnc.15023. Epub 2020 May 9.

Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

Manduca JD, Thériault RK, Perreault ML.

Pharmacol Res. 2020 Jul;157:104819. doi: 10.1016/j.phrs.2020.104819. Epub 2020 Apr 17.

Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review

Pei H, Ma L, Cao Y, Wang F, Li Z, Liu N, Liu M, Wei Y, Li H.

Am J Chin Med. 2020;48(3):487-511. doi: 10.1142/S0192415X20500251. Epub 2020 Apr 24.

An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Chan Kwong A, Cassé-Perrot C, Costes-Salon MC, Jouve E, Lanteaume L, Audebert C, Rouby F, Lefebvre MN, Ranjeva JP, Beck A, Deplanque D, Ponchel A, Vervueren C, Truillet R, Babilon C, Auffret A, Richardson JC, Payoux P, Bartrés-Faz D, Blin O, Bordet R, Micallef J; Pharmacog Consortium.

J Clin Psychopharmacol. 2020 May/Jun;40(3):222-230. doi: 10.1097/JCP.0000000000001199.

Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs

Avgerinos KI, Vrysis C, Chaitidis N, Kolotsiou K, Myserlis PG, Kapogiannis D.

Neurol Sci. 2020 Oct;41(10):2747-2754. doi: 10.1007/s10072-020-04427-0. Epub 2020 May 23.

Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies

Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):158-164. doi: 10.14283/jpad.2020.19.

Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting

Sabbagh MN, Boada M, Borson S, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):171-178. doi: 10.14283/jpad.2020.22.

Treatment Development for Alzheimer's Disease: How Are We Doing?

Lyketsos CG.

Adv Exp Med Biol. 2020;1195:19. doi: 10.1007/978-3-030-32633-3_3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias